Happy to have contributed to this preprint with Fangzhu Zhao and @realJimWells! LRP8-targeted bispecific antibody degraders degrade the selenium uptake receptor LRP8, reduce GPX4 / selenoproteins, and sensitize cancer cells to ferroptosis.
https://t.co/Ue9HCnnyrI
Vitória brasileira: Fruto do esforço científico nacional, a Butantan-DV começou a ser desenvolvida em 2009, quando o Brasil enfrentava recordes de dengue. Foram 270 experimentos e 50 tentativas de formulação até chegar ao produto final. Saiba mais: https://t.co/Jq1CnueM1I
Proud for being launching our Center of Metabolism at USP!!! Together with my colleagues @AJKowaltowski@sayuri_miyamoto e Marilia Seelander we are creating CoMeta. Take a look below to know more about this: https://t.co/oMrXTnSmDc
Excited to share our new study out in @NatureCellBio! Led by postdoc @MikeLangePhD, we identify the first #LipidDroplet lipid quality control pathway: LD-localized FSP1 protects stored lipids from oxidative damage and prevents LD-initiated #ferroptosis.
https://t.co/QBM8e07IlC
Happy to have contributed in a small way to this exciting story from Fangzhu Zhao and @realJimWells now out in @J_A_C_S.
"Hijacking Extracellular Targeted Protein Degrader–Drug Conjugates for Enhanced Drug Delivery"
https://t.co/WTuIi5Qdg9
Congratulations to @BerkeleyMetBio professor @apsarruda and postdoc @AlexInague, who each received multiyear grants from @pewtrusts to support their research and professional growth. Read more: https://t.co/jVJpuWbhdR
🎉Congrats to our 2025 biomedical scholars and fellows!
These 37 early-career scientists are embarking on innovative research projects in neuroscience, microbiology, cancer research, and more. https://t.co/W5zNjPA0fh
My lab's first paper is out in @Nature. We show that lipoprotein uptake protects tumors from ferroptosis by delivering the lipid antioxidant α-tocopherol. Surprisingly, tumors use sulfated glycosaminoglycans—not canonical receptors—to capture lipoproteins. https://t.co/NBv1sUXxJ5
Exciting new work from @looogannn & Scott Dixon in @nchembio! Tegavivint, a clinical-stage drug, triggers a novel lipid-dependent nonapoptotic cell death via TECR and palmitate synthesis. Very cool! 🤩
https://t.co/QeXaATKXox
Reminder: The 1st FASEB #Ferroptosis Meeting is this summer! Spectacular speaker lineup + short talks selected from submitted abstracts. It is going to be awesome! Trainees, newcomers & all interested are welcome!
📅 Abstract deadline: June 1, 2025.
https://t.co/XF2CZdNJND
Excited to share our new preprint! Exceptional work by postdoc @MikeLange identifies the first #LipidDroplet lipid quality control pathway! Droplet-localized FSP1 safeguards stored neutral lipids, blocking their peroxidation & #ferroptosis induction.🤩https://t.co/x6OEzcSafI
New paper is out!🎄🥳
Identification of Novel Human 15-Lipoxygenase-2 (h15-LOX-2) Inhibitors Using a Virtual Screening Approach.
Congratulations to all authors! @lucasgviv, Thais Iijima, Erika Piccirllo, Leandro Rezende, Thiago Alegria, Luis Neto +
https://t.co/1dfSkZTs7F
Immunologist Dr. Gabriel D. Victora shares how he changed career paths from classical pianist to immunologist and discusses the importance of not letting technological limitations get in the way. #50ScientistsThatInspire#CP50
Read the full interview:
https://t.co/JxI4LrP9WE
Grateful to @berkeleyMCB for highlighting our lab and our recent discoveries! It was fun to discuss some of the surprises during our research on lipid homeostasis, lipid droplets, & ferroptosis—driven by exceptional UC Berkeley students & postdocs. https://t.co/UZNNmq1NvX
I’m happy to share this good news from @usponline ! 🥳
A huge thank you to all the professors, lab colleagues, and friends who played an essential role in the development of my thesis and the resulting articles!!
@MiyamotoLab https://t.co/6cCgabRWr9
Our Molecular Therapeutics department @UCBerkeley is looking for a Metabolomics Specialist! If you're skilled in untargeted and targeted metabolomics applications and want to contribute to the discovery of novel biology and drugs then this is for you! https://t.co/h2QGi6j89m